On September 30, 2013, a new antidepressant, vortioxetine (Brintellix™), produced and comarketed by Lundbeck and Takeda, was approved by the US Food and Drug Administration. The recommended starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback